FDA Office of Research Resources
Position of acting director of Research and Testing Division is currently held on a rotating basis by 14 to 18 senior scientists. Acting Director James Kotteman retired from the agency in June. FDA has postponed a search for a replacement until the restructuring of the division is completed. FDA is actively looking for a permanent director of the office and to relieve Acting Deputy Director Jerome Skelly, PhD, from his other position as director of the Division of Biopharmaceutics.
You may also be interested in...
The UK’s deployment of COVID-19 vaccines has left vaccine manufacturers worried about emerging discussions on dosing strategies that may not be supported by authorized labeling or published clinical data.
The French biotech's chances of competing with Aimmune's Palforzia in the peanut allergy market have been boosted after US regulators decided that a fresh Phase III trial for the Viaskin Peanut patch would not be required for resubmission.
COVID-19 has not held back GSK's preparations to create the world's largest standalone consumer health business, with CEO Emma Walmsley confirming separation is on track for summer next year.